Application | Comment | Organism |
---|---|---|
medicine | combination of DPP IV inhibitor with low dose of thiazolidinedione can interact synergistically to represent a therapeutic advantage for the clinical treatment of type 2 diabetes without the adverse effects of haemodilution and weight gain associated with thiazolidinediones | Mus musculus |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
LAF-237 | - |
Mus musculus | |
vildagliptin | - |
Mus musculus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Mus musculus | - |
- |
- |
Synonyms | Comment | Organism |
---|---|---|
DPP IV | - |
Mus musculus |